US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ATS Corp.

18.26

+0.23001.28%

Post-market: 18.260.00000.00%19:30 EDT

Volume:188.16K

Turnover:3.43M

Market Cap:1.79B

PE:54.31

High:18.39

Open:18.26

Low:17.99

Close:18.03

52wk High:35.82

52wk Low:17.77

Shares:98.13M

Float Shares:74.46M

Volume Ratio:0.81

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3362

EPS(LYR):0.5242

ROE:2.69%

ROA:2.92%

PB:1.42

PE(LYR):34.83

Loading ...

Overview Company News Filings

Savara presents poster at ATS 2026 International Conference on IMPALA-2

Entravision Rides ATS Surge in Latest Earnings Call

BLUE OCEAN TECHNOLOGIES APPOINTS WILLIAM GOODBODY, JR. AS HEAD OF MARKET OPERATIONS FOR BLUE OCEAN ATS IN AUSTRALIA

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference

ATS Corporation Sets May 28, 2026 Fourth-Quarter Earnings Call

Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says

MT Newswires Live

Press Release: MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

Press Release: ATS to Host Fourth Quarter Earnings Call Thursday May 28, 2026, at 8:30 a.m. Eastern

Press Release: Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

Press Release: Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

Calendar of U.S. Earnings Expected in the Week Ahead

RBC Capital Keeps Their Buy Rating on ATS Corporation (ATS)

Australis Oil & Gas launches market-linked long term incentive plan for employees

Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026

Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Entravision’s Earnings Call: ATS Fuels Profitable Turnaround

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/ATS/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ATS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATS\",,,,,undefined,":{"symbol":"ATS","market":"US","secType":"STK","nameCN":"ATS Corp.","latestPrice":18.26,"timestamp":1790971200000,"preClose":18.03,"halted":0,"volume":188155,"hourTrading":{"tag":"盘后","latestPrice":18.26,"preClose":18.26,"latestTime":"19:30 EDT","volume":21496,"amount":392877.368348,"timestamp":1790983807859,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.012756516916250717,"floatShares":74458000,"shares":98126900,"eps":0.336239,"marketStatus":"Market Closed","change":0.23,"latestTime":"10-02 16:00:00 EDT","open":18.26,"high":18.39,"low":17.99,"amount":3426352.2229199996,"amplitude":0.022185,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.336239,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1684987200000,"exchange":"NYSE","adjPreClose":18.03,"postHourTrading":{"tag":"盘后","latestPrice":18.26,"preClose":18.26,"latestTime":"19:30 EDT","volume":21496,"amount":392877.368348,"timestamp":1790983807859,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8055283941260629,"impliedVol":0.5516,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATS\",,,,,undefined,":{"symbol":"ATS","floatShares":74458000,"roa":"2.92%","roe":"2.69%","lyrEps":0.524235,"volumeRatio":0.8055283941260629,"shares":98126900,"dividePrice":0,"high":18.39,"amplitude":0.022185,"preClose":18.03,"low":17.99,"week52Low":17.7676,"pbRate":"1.42","psRate":"0.87","week52High":35.82,"institutionHeld":0,"latestPrice":18.26,"eps":0.336239,"divideRate":0,"volume":188155,"delay":0,"ttmEps":0.336239,"open":18.26,"prevYearClose":27.54,"prevWeekClose":19.1,"prevMonthClose":18.05,"prevQuarterClose":18.05,"fiveDayClose":19.1,"twentyDayClose":19.57,"sixtyDayClose":27.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ATS","fiscalQuarterEnding":"2026/06","expectedEps":0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2026-05-28","symbol":"ATS","fiscalQuarterEnding":"2026/03","expectedEps":0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1779940800000,"reportTimeType":"pre","actualEps":0.26},{"market":"US","date":"2026-02-04","symbol":"ATS","fiscalQuarterEnding":"2025/12","expectedEps":0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770181200000,"reportTimeType":"pre","actualEps":0.23},{"market":"US","date":"2025-11-05","symbol":"ATS","fiscalQuarterEnding":"2025/09","expectedEps":0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":0.33},{"market":"US","date":"2025-08-07","symbol":"ATS","fiscalQuarterEnding":"2025/06","expectedEps":0.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":1,"strongSell":0,"meanLabel":"SELL","meanPercent":1,"analysts":1,"updateTime":1771473600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATS","date":"2026-10-02","current":54.306609,"percent":0.820197,"low":-897.033197,"twenty":-91.85093,"median":33.592349,"eighty":51.050572,"high":254.533797,"avg":-29.711065,"sd":236.177835,"marketCap":1744912345.88},"quantilePoints":[{"date":"2023-06-02","current":46.343344,"twenty":46.194425,"median":46.266425,"eighty":46.306886,"marketCap":4385290976.46},{"date":"2023-06-09","current":46.009827,"twenty":46.17581,"median":46.28258,"eighty":46.915752,"marketCap":4390539453.8},{"date":"2023-06-16","current":45.438012,"twenty":45.320112,"median":46.164952,"eighty":46.476751,"marketCap":4375388926.84},{"date":"2023-06-23","current":48.145057,"twenty":45.487654,"median":46.266425,"eighty":47.860268,"marketCap":4658766213.85},{"date":"2023-06-30","current":46.896248,"twenty":45.651659,"median":46.266425,"eighty":47.485058,"marketCap":4511580364.18},{"date":"2023-07-07","current":46.270844,"twenty":46.009827,"median":46.312962,"eighty":47.5378,"marketCap":4411747145.22},{"date":"2023-07-14","current":48.698172,"twenty":46.043025,"median":46.511353,"eighty":47.780498,"marketCap":4728914205.59},{"date":"2023-07-21","current":48.480908,"twenty":46.105078,"median":46.872979,"eighty":48.286922,"marketCap":4686318579.71},{"date":"2023-07-28","current":45.850462,"twenty":46.043025,"median":46.851428,"eighty":48.286922,"marketCap":4428020690.86},{"date":"2023-08-04","current":44.368411,"twenty":46.009827,"median":46.763285,"eighty":48.152813,"marketCap":4237745227.85},{"date":"2023-08-11","current":42.700705,"twenty":45.438012,"median":46.511353,"eighty":48.145057,"marketCap":4326916372.16},{"date":"2023-08-18","current":40.050115,"twenty":44.926078,"median":46.32649,"eighty":48.075247,"marketCap":4021626143.41},{"date":"2023-08-25","current":41.899702,"twenty":43.443089,"median":46.270844,"eighty":48.061899,"marketCap":4194356348.69},{"date":"2023-08-31","current":43.312379,"twenty":42.678859,"median":46.219245,"eighty":47.836778,"marketCap":4344740041.37},{"date":"2023-09-08","current":43.843953,"twenty":42.897314,"median":46.105078,"eighty":47.634879,"marketCap":4353234860.78},{"date":"2023-09-15","current":43.042951,"twenty":42.657014,"median":45.930144,"eighty":47.433983,"marketCap":4325894000.62},{"date":"2023-09-22","current":41.921548,"twenty":42.559437,"median":45.562117,"eighty":47.311701,"marketCap":4220969734.92},{"date":"2023-09-29","current":42.533222,"twenty":42.508464,"median":45.081733,"eighty":47.274981,"marketCap":4280367687.17},{"date":"2023-10-06","current":40.050115,"twenty":42.428364,"median":44.926078,"eighty":47.160162,"marketCap":3958860964.51},{"date":"2023-10-13","current":39.423877,"twenty":42.00893,"median":44.615828,"eighty":47.035061,"marketCap":3917634187.34},{"date":"2023-10-20","current":36.088795,"twenty":41.126371,"median":44.229891,"eighty":46.935301,"marketCap":3572025991.12},{"date":"2023-10-27","current":34.661554,"twenty":40.778231,"median":44.058847,"eighty":46.909266,"marketCap":3403618402.31},{"date":"2023-11-03","current":33.358105,"twenty":40.050115,"median":43.843953,"eighty":46.860392,"marketCap":3284508208.07},{"date":"2023-11-10","current":31.05346,"twenty":39.978754,"median":43.47968,"eighty":46.850053,"marketCap":3541182846.54},{"date":"2023-11-17","current":33.712074,"twenty":39.645245,"median":43.312379,"eighty":46.711431,"marketCap":3845894896.75},{"date":"2023-11-24","current":33.592349,"twenty":38.190334,"median":43.072078,"eighty":46.623309,"marketCap":3848769791.51},{"date":"2023-12-01","current":33.655362,"twenty":35.166914,"median":42.886392,"eighty":46.541855,"marketCap":3891785593.98},{"date":"2023-12-08","current":33.604952,"twenty":34.322082,"median":42.591477,"eighty":46.44537,"marketCap":3879525100.59},{"date":"2023-12-15","current":35.923838,"twenty":34.218738,"median":42.507736,"eighty":46.366559,"marketCap":4204253502},{"date":"2023-12-22","current":36.07507,"twenty":34.272496,"median":42.474968,"eighty":46.323119,"marketCap":4257700834.69},{"date":"2023-12-29","current":36.289315,"twenty":34.310293,"median":42.423994,"eighty":46.304224,"marketCap":4315633982.44},{"date":"2024-01-05","current":34.650971,"twenty":34.327977,"median":42.161849,"eighty":46.287991,"marketCap":4072504954.25},{"date":"2024-01-12","current":35.442932,"twenty":34.397952,"median":41.910625,"eighty":46.273191,"marketCap":4139113955.77},{"date":"2024-01-19","current":36.274955,"twenty":34.423844,"median":41.655761,"eighty":46.2585,"marketCap":4216951441.35},{"date":"2024-01-26","current":36.917882,"twenty":34.562753,"median":40.778299,"eighty":46.231655,"marketCap":4292072985.19},{"date":"2024-02-02","current":36.987217,"twenty":34.654752,"median":40.235802,"eighty":46.154093,"marketCap":4330447033.68},{"date":"2024-02-09","current":31.2472,"twenty":34.423844,"median":40.050115,"eighty":46.10731,"marketCap":4053209917.9},{"date":"2024-02-16","current":29.911027,"twenty":34.218738,"median":40.010065,"eighty":46.067846,"marketCap":3869003534.07},{"date":"2024-02-23","current":28.569192,"twenty":34.062459,"median":39.908119,"eighty":46.029746,"marketCap":3697982548.6},{"date":"2024-03-01","current":28.954191,"twenty":33.729718,"median":39.700587,"eighty":45.946081,"marketCap":3727658474.68},{"date":"2024-03-08","current":28.897573,"twenty":33.622723,"median":38.630157,"eighty":45.760452,"marketCap":3749905081.21},{"date":"2024-03-15","current":28.33706,"twenty":33.535637,"median":37.535596,"eighty":45.60011,"marketCap":3663186667.6},{"date":"2024-03-22","current":28.378306,"twenty":33.360741,"median":37.125888,"eighty":45.512475,"marketCap":3664397837.7},{"date":"2024-03-28","current":27.463826,"twenty":33.187804,"median":36.956482,"eighty":45.379062,"marketCap":3545999564.77},{"date":"2024-04-05","current":25.261057,"twenty":31.829239,"median":36.880063,"eighty":45.11865,"marketCap":3270651387.12},{"date":"2024-04-12","current":24.173756,"twenty":30.404732,"median":36.432536,"eighty":45.004481,"marketCap":3078077137.88},{"date":"2024-04-19","current":24.609778,"twenty":29.677763,"median":36.289315,"eighty":44.938488,"marketCap":3127556802.58},{"date":"2024-04-26","current":25.396884,"twenty":29.011941,"median":36.169269,"eighty":44.868397,"marketCap":3239367008.29},{"date":"2024-05-03","current":25.125077,"twenty":28.84322,"median":36.062467,"eighty":44.633305,"marketCap":3203669221.23},{"date":"2024-05-10","current":26.025435,"twenty":28.633736,"median":35.997283,"eighty":44.566345,"marketCap":3323128791.91},{"date":"2024-05-17","current":23.786609,"twenty":28.457413,"median":35.841921,"eighty":44.342163,"marketCap":3384597470.53},{"date":"2024-05-24","current":21.936652,"twenty":28.195987,"median":35.701363,"eighty":44.23426,"marketCap":3102092113.2},{"date":"2024-05-31","current":21.435159,"twenty":27.970637,"median":35.598334,"eighty":44.222609,"marketCap":3039383806.02},{"date":"2024-06-07","current":22.690097,"twenty":27.463826,"median":35.382456,"eighty":43.895086,"marketCap":3211638521.11},{"date":"2024-06-14","current":22.285278,"twenty":26.048085,"median":35.173981,"eighty":43.895086,"marketCap":3139567043.35},{"date":"2024-06-21","current":21.323834,"twenty":25.875989,"median":34.8436,"eighty":43.864406,"marketCap":3015344623.92},{"date":"2024-06-28","current":22.482628,"twenty":25.849972,"median":34.751792,"eighty":43.843953,"marketCap":3180274284.27},{"date":"2024-07-05","current":21.972427,"twenty":25.639244,"median":34.657272,"eighty":43.651713,"marketCap":3127376247.29},{"date":"2024-07-12","current":22.998515,"twenty":25.494281,"median":34.422199,"eighty":43.533747,"marketCap":3270585876.4},{"date":"2024-07-15","current":22.953023,"twenty":25.430859,"median":34.413972,"eighty":43.516271,"marketCap":3254489261.98},{"date":"2024-08-02","current":20.309458,"twenty":25.403679,"median":34.373922,"eighty":43.501635,"marketCap":2841766295.19},{"date":"2024-08-09","current":20.723514,"twenty":25.129607,"median":34.224644,"eighty":43.440249,"marketCap":2735666122.5},{"date":"2024-08-16","current":19.860035,"twenty":24.796645,"median":34.162619,"eighty":43.405587,"marketCap":2630022203.9},{"date":"2024-08-23","current":19.838448,"twenty":24.268888,"median":33.920018,"eighty":43.283252,"marketCap":2645505418.49},{"date":"2024-08-30","current":19.471469,"twenty":23.8321,"median":33.734128,"eighty":43.147809,"marketCap":2621186477.04},{"date":"2024-09-06","current":18.602592,"twenty":23.494241,"median":33.671115,"eighty":43.072078,"marketCap":2495925620.93},{"date":"2024-09-13","current":19.185441,"twenty":22.907687,"median":33.604952,"eighty":43.042951,"marketCap":2560815499.76},{"date":"2024-09-20","current":20.831449,"twenty":22.803751,"median":33.570295,"eighty":43.028387,"marketCap":2786196948.41},{"date":"2024-09-27","current":21.948725,"twenty":22.594145,"median":33.45372,"eighty":42.744396,"marketCap":2956487278.6},{"date":"2024-10-04","current":21.646505,"twenty":22.472834,"median":33.3614,"eighty":42.700705,"marketCap":2900362552.24},{"date":"2024-10-11","current":21.560157,"twenty":22.285278,"median":33.233174,"eighty":42.591477,"marketCap":2843647655.11},{"date":"2024-10-18","current":22.617927,"twenty":22.261739,"median":32.698187,"eighty":42.533222,"marketCap":2977792893.11},{"date":"2024-10-25","current":22.645897,"twenty":22.285278,"median":31.73976,"eighty":42.511377,"marketCap":2967565955.08},{"date":"2024-10-31","current":23.088453,"twenty":22.329808,"median":31.05346,"eighty":42.505551,"marketCap":3006452868.32},{"date":"2024-11-08","current":30.478219,"twenty":22.389519,"median":30.568298,"eighty":42.486619,"marketCap":2853731574.85},{"date":"2024-11-15","current":30.530988,"twenty":22.401664,"median":30.478219,"eighty":42.476424,"marketCap":2830133907.78},{"date":"2024-11-22","current":30.757144,"twenty":22.402758,"median":30.568681,"eighty":42.451666,"marketCap":2862659955.58},{"date":"2024-11-29","current":33.961013,"twenty":22.434826,"median":30.673837,"eighty":42.419625,"marketCap":3148783777.17},{"date":"2024-12-06","current":34.669633,"twenty":22.46611,"median":30.907914,"eighty":42.257969,"marketCap":3210086264.85},{"date":"2024-12-13","current":33.207161,"twenty":22.47871,"median":31.108842,"eighty":42.148741,"marketCap":3040755582.89},{"date":"2024-12-20","current":31.48838,"twenty":22.488641,"median":31.48838,"eighty":42.00893,"marketCap":2849502272.41},{"date":"2024-12-27","current":33.734858,"twenty":22.494713,"median":31.970845,"eighty":41.91281,"marketCap":3041459063.87},{"date":"2025-01-03","current":33.410701,"twenty":22.507997,"median":32.326091,"eighty":41.867662,"marketCap":3006099952.21},{"date":"2025-01-10","current":30.583758,"twenty":22.548751,"median":32.187154,"eighty":41.739502,"marketCap":2758779888.76},{"date":"2025-01-17","current":28.714206,"twenty":22.594145,"median":31.76484,"eighty":41.57202,"marketCap":2591110278.91},{"date":"2025-01-24","current":30.922991,"twenty":22.613171,"median":31.446918,"eighty":40.977822,"marketCap":2794075415.08},{"date":"2025-01-31","current":29.754521,"twenty":22.627085,"median":31.164224,"eighty":40.788494,"marketCap":2682414705.78},{"date":"2025-02-07","current":44.52783,"twenty":22.642592,"median":31.108842,"eighty":40.977822,"marketCap":2778433490.84},{"date":"2025-02-14","current":46.096561,"twenty":22.681257,"median":31.405456,"eighty":41.965239,"marketCap":2894690862.79},{"date":"2025-02-21","current":45.29574,"twenty":22.741461,"median":31.73976,"eighty":42.419625,"marketCap":2847627453.27},{"date":"2025-02-28","current":46.79865,"twenty":22.792532,"median":32.079,"eighty":42.507008,"marketCap":2895255396.7},{"date":"2025-03-07","current":41.862084,"twenty":22.806185,"median":32.332694,"eighty":42.635168,"marketCap":2622361985.36},{"date":"2025-03-14","current":41.423278,"twenty":22.822194,"median":32.713389,"eighty":42.635168,"marketCap":2565848922.04},{"date":"2025-03-21","current":43.880591,"twenty":22.853037,"median":32.981006,"eighty":43.034213,"marketCap":2732813300.12},{"date":"2025-03-28","current":42.224099,"twenty":22.88278,"median":33.123373,"eighty":43.054602,"marketCap":2633489494.72},{"date":"2025-04-04","current":39.042756,"twenty":22.901877,"median":33.222238,"eighty":43.034213,"marketCap":2482102274.67},{"date":"2025-04-11","current":36.168577,"twenty":22.907687,"median":33.258379,"eighty":42.953904,"marketCap":2303349084},{"date":"2025-04-17","current":36.662234,"twenty":22.91307,"median":33.3614,"eighty":42.840307,"marketCap":2360722684.91},{"date":"2025-04-25","current":38.011562,"twenty":22.933896,"median":33.415912,"eighty":42.72692,"marketCap":2443342344.25},{"date":"2025-05-02","current":38.318726,"twenty":22.957542,"median":33.501164,"eighty":42.694361,"marketCap":2471450690},{"date":"2025-05-09","current":38.494248,"twenty":22.972956,"median":33.554541,"eighty":42.647498,"marketCap":2471983722.75},{"date":"2025-05-16","current":42.432532,"twenty":22.990951,"median":33.59865,"eighty":42.694361,"marketCap":2705638771.71},{"date":"2025-05-23","current":39.240219,"twenty":23.03449,"median":33.649379,"eighty":42.706785,"marketCap":2525720011.68},{"date":"2025-05-30","current":-145.081888,"twenty":22.98843,"median":33.649379,"eighty":42.736874,"marketCap":2948051518.8},{"date":"2025-06-06","current":-141.392185,"twenty":22.910379,"median":33.59865,"eighty":42.706785,"marketCap":2905577142.42},{"date":"2025-06-13","current":-147.065973,"twenty":22.838868,"median":33.554541,"eighty":42.705569,"marketCap":3029340885.66},{"date":"2025-06-20","current":-147.588101,"twenty":22.775703,"median":33.508702,"eighty":42.700705,"marketCap":3013637808.62},{"date":"2025-06-27","current":-151.382229,"twenty":22.617927,"median":33.434816,"eighty":42.684845,"marketCap":3112877198.05},{"date":"2025-07-03","current":-154.340953,"twenty":22.496776,"median":33.387698,"eighty":42.610151,"marketCap":3191028919.77},{"date":"2025-07-11","current":-140.452356,"twenty":22.445425,"median":33.283584,"eighty":42.544873,"marketCap":2878692397.63},{"date":"2025-07-18","current":-148.841207,"twenty":22.329808,"median":33.214699,"eighty":42.515746,"marketCap":3036782441.3},{"date":"2025-07-25","current":-150.163931,"twenty":22.224904,"median":33.070283,"eighty":42.505551,"marketCap":3090657544.76},{"date":"2025-08-01","current":-146.369803,"twenty":21.983688,"median":33.000575,"eighty":42.486619,"marketCap":2966528128.91},{"date":"2025-08-08","current":-101.054949,"twenty":21.94631,"median":32.80762,"eighty":42.476424,"marketCap":2880442495.37},{"date":"2025-08-15","current":-97.518773,"twenty":21.761929,"median":32.336463,"eighty":42.451666,"marketCap":2771168115.02},{"date":"2025-08-22","current":-92.314119,"twenty":21.629235,"median":32.187154,"eighty":42.435194,"marketCap":2605351661.45},{"date":"2025-08-29","current":-94.430844,"twenty":21.416942,"median":31.76484,"eighty":42.408226,"marketCap":2690809366.58},{"date":"2025-09-05","current":-94.231623,"twenty":21.21908,"median":31.446918,"eighty":42.295319,"marketCap":2669825633.28},{"date":"2025-09-12","current":-95.028508,"twenty":20.931914,"median":31.164224,"eighty":42.186749,"marketCap":2693629533.12},{"date":"2025-09-19","current":-96.921109,"twenty":20.265687,"median":30.941837,"eighty":42.148741,"marketCap":2753845197.92},{"date":"2025-09-26","current":-91.367818,"twenty":19.971207,"median":30.757144,"eighty":42.098311,"marketCap":2572349952.97},{"date":"2025-10-03","current":-91.467429,"twenty":19.836289,"median":30.673837,"eighty":41.981136,"marketCap":2565172507.46},{"date":"2025-10-10","current":-91.890774,"twenty":19.770448,"median":30.583758,"eighty":41.90844,"marketCap":2570628933.63},{"date":"2025-10-17","current":-92.538243,"twenty":19.536178,"median":30.429218,"eighty":41.877131,"marketCap":2583489123.67},{"date":"2025-10-24","current":-94.057305,"twenty":19.426136,"median":30.327448,"eighty":41.829173,"marketCap":2635618172.4},{"date":"2025-10-31","current":-92.861977,"twenty":19.191917,"median":30.172909,"eighty":41.766594,"marketCap":2604412516.09},{"date":"2025-11-07","current":-840.478534,"twenty":18.877826,"median":30.012938,"eighty":41.639013,"marketCap":2763562438.19},{"date":"2025-11-14","current":-794.27753,"twenty":-24.454255,"median":29.885544,"eighty":41.482775,"marketCap":2634611431.77},{"date":"2025-11-21","current":-720.44031,"twenty":-90.690466,"median":29.754521,"eighty":41.357457,"marketCap":2378964442.77},{"date":"2025-11-28","current":-749.131344,"twenty":-91.427585,"median":29.66191,"eighty":41.252143,"marketCap":2481656418.02},{"date":"2025-12-05","current":-772.548291,"twenty":-92.025248,"median":29.434134,"eighty":41.138054,"marketCap":2574939374.84},{"date":"2025-12-12","current":-806.302449,"twenty":-92.468515,"median":29.33919,"eighty":40.994795,"marketCap":2719740619.47},{"date":"2025-12-19","current":-802.71607,"twenty":-92.687659,"median":29.038708,"eighty":40.808883,"marketCap":2711086457.01},{"date":"2025-12-26","current":-818.116404,"twenty":-92.881899,"median":28.925882,"eighty":40.778231,"marketCap":2780190128.31},{"date":"2026-01-02","current":-797.652946,"twenty":-93.036296,"median":28.85511,"eighty":40.777958,"marketCap":2701366821.38},{"date":"2026-01-09","current":-829.523643,"twenty":-93.982597,"median":28.79,"eighty":40.732159,"marketCap":2780572966.83},{"date":"2026-01-16","current":-897.033197,"twenty":-94.20672,"median":28.721744,"eighty":40.421489,"marketCap":3000957491.22},{"date":"2026-01-23","current":-852.94102,"twenty":-94.306331,"median":28.652131,"eighty":40.345308,"marketCap":2872825063.23},{"date":"2026-01-30","current":-822.139786,"twenty":-94.500572,"median":28.625809,"eighty":40.26483,"marketCap":2822985227.98},{"date":"2026-02-06","current":208.384924,"twenty":-94.699793,"median":28.600331,"eighty":40.345308,"marketCap":2876417798.07},{"date":"2026-02-13","current":217.783795,"twenty":-94.679871,"median":28.638821,"eighty":40.788494,"marketCap":3016893475.65},{"date":"2026-02-20","current":231.284936,"twenty":-94.545397,"median":28.714206,"eighty":41.221427,"marketCap":3190649761.48},{"date":"2026-02-27","current":231.233009,"twenty":-94.440805,"median":28.789796,"eighty":41.766594,"marketCap":3191752106.95},{"date":"2026-03-06","current":221.5745,"twenty":-94.430844,"median":28.835294,"eighty":41.981136,"marketCap":3051363607.19},{"date":"2026-03-13","current":200.855441,"twenty":-94.356136,"median":28.925882,"eighty":42.295319,"marketCap":2784391762.71},{"date":"2026-03-20","current":221.5745,"twenty":-94.306331,"median":29.083593,"eighty":42.477881,"marketCap":3051096603.42},{"date":"2026-03-27","current":212.798758,"twenty":-94.261506,"median":29.339504,"eighty":42.556524,"marketCap":2902003820.96},{"date":"2026-04-02","current":208.384924,"twenty":-94.231623,"median":29.434134,"eighty":42.704353,"marketCap":2827964511.21},{"date":"2026-04-10","current":220.172459,"twenty":-94.221662,"median":29.66191,"eighty":42.891084,"marketCap":3007447997.08},{"date":"2026-04-17","current":223.288107,"twenty":-94.186798,"median":29.795983,"eighty":43.045296,"marketCap":3074984579.03},{"date":"2026-04-24","current":242.189704,"twenty":-94.117071,"median":29.911027,"eighty":43.246201,"marketCap":3342818367},{"date":"2026-05-01","current":228.844345,"twenty":-94.057305,"median":30.049577,"eighty":43.475217,"marketCap":3174723129.99},{"date":"2026-05-08","current":246.272749,"twenty":-94.027422,"median":30.199294,"eighty":43.611845,"marketCap":3409841478.72},{"date":"2026-05-15","current":231.205429,"twenty":-93.952714,"median":30.334384,"eighty":43.895086,"marketCap":3179217752.6},{"date":"2026-05-22","current":235.985407,"twenty":-93.748512,"median":30.478219,"eighty":44.315916,"marketCap":3232400113.88},{"date":"2026-05-29","current":57.523315,"twenty":-93.439719,"median":30.583758,"eighty":44.536606,"marketCap":2984982176.15},{"date":"2026-06-05","current":53.770604,"twenty":-93.135906,"median":30.673837,"eighty":44.890309,"marketCap":2770878710.36},{"date":"2026-06-12","current":51.072486,"twenty":-93.021354,"median":30.757144,"eighty":44.999546,"marketCap":2612540227.64},{"date":"2026-06-18","current":54.770414,"twenty":-92.961588,"median":30.922991,"eighty":45.218949,"marketCap":2776051661.63},{"date":"2026-06-26","current":54.729326,"twenty":-92.961588,"median":31.108842,"eighty":45.537083,"marketCap":2762476455.87},{"date":"2026-07-02","current":55.98936,"twenty":-92.901822,"median":31.326328,"eighty":45.76965,"marketCap":2827451643.92},{"date":"2026-07-10","current":53.811692,"twenty":-92.866958,"median":31.73976,"eighty":46.016467,"marketCap":2721009214.95},{"date":"2026-07-17","current":53.551467,"twenty":-92.822133,"median":32.079,"eighty":46.098264,"marketCap":2732558690.37},{"date":"2026-07-24","current":51.017702,"twenty":-92.752406,"median":32.332694,"eighty":46.164576,"marketCap":2593422796.68},{"date":"2026-07-31","current":51.414887,"twenty":-92.662756,"median":32.619157,"eighty":46.2585,"marketCap":2628572436.16},{"date":"2026-08-07","current":58.956307,"twenty":-92.598009,"median":32.916928,"eighty":46.323119,"marketCap":1983485975},{"date":"2026-08-14","current":57.723341,"twenty":-92.573107,"median":33.048853,"eighty":46.623309,"marketCap":1954834878.45},{"date":"2026-08-21","current":54.764224,"twenty":-92.548204,"median":33.191812,"eighty":46.869356,"marketCap":1877081843.92},{"date":"2026-08-28","current":55.175212,"twenty":-92.433652,"median":33.233174,"eighty":47.274981,"marketCap":1879054542.77},{"date":"2026-09-04","current":55.524552,"twenty":-92.334041,"median":33.3614,"eighty":47.893058,"marketCap":1901224013.26},{"date":"2026-09-11","current":54.16829,"twenty":-92.274275,"median":33.413307,"eighty":48.149711,"marketCap":1850663349.86},{"date":"2026-09-18","current":55.23686,"twenty":-92.174664,"median":33.493625,"eighty":48.504823,"marketCap":1863770310.18},{"date":"2026-09-25","current":54.90807,"twenty":-92.025248,"median":33.538787,"eighty":49.3391,"marketCap":1832274186.8},{"date":"2026-10-02","current":52.668182,"twenty":-91.85093,"median":33.592349,"eighty":51.050572,"marketCap":1744912345.88}],"updateTime":1791091417579},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATS\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636842847","title":"Savara presents poster at ATS 2026 International Conference on IMPALA-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2636842847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636842847?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:22","pubTimestamp":1779279748,"startTime":"0","endTime":"0","summary":"Savara (SVRA) presented a poster at the ATS 2026 International Conference that is taking place May 15-20, 2026, in Orlando, Florida. The poster rep...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-presents-poster-at-ats-2026-international-conference-on-impala-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-presents-poster-at-ats-2026-international-conference-on-impala-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATS","SVRA","BK4139","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636899581","title":"Entravision Rides ATS Surge in Latest Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899581","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899581?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:39","pubTimestamp":1779241157,"startTime":"0","endTime":"0","summary":"Entravision Communications Corporation Class A (($EVC)) has held its Q1 earnings call. Read on for the main highlights of the call. Entravision Com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/entravision-rides-ats-surge-in-latest-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/entravision-rides-ats-surge-in-latest-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVC","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636968860","title":"BLUE OCEAN TECHNOLOGIES APPOINTS WILLIAM GOODBODY, JR. AS HEAD OF MARKET OPERATIONS FOR BLUE OCEAN ATS IN AUSTRALIA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636968860","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636968860?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:35","pubTimestamp":1779230100,"startTime":"0","endTime":"0","summary":"Strategic Appointment Expands Blue Ocean Technologies' Presence Across the APAC Region. Bill brings more than 30 years of experience spanning global equities, foreign exchange, and digital assets across major financial centers in the United States, Europe, and APAC. Throughout his career, he has held senior leadership positions at globally recognized firms including Bats Global Markets, Hotspot FX, Knight Capital Group, AE Capital, and Zerocap.Brian Hyndman, CEO of Blue Ocean Technologies commented, \"Bill's deep operational expertise, institutional market knowledge, and extensive capital markets experience building and scaling global trading businesses make him an exceptional addition to the Blue Ocean ATS team. In his new role, Bill will focus on enhancing operational capabilities, supporting strategic partnerships, and accelerating Blue Ocean Technologies' growth initiatives throughout APAC. This appointment marks an important milestone in our international growth strategy as we cont","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/blue-ocean-technologies-appoints-william-goodbody-jr-as-head-of-market-operations-for-blue-ocean-ats-in-australia-302776886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BOT.AU","NMS","ATS","BK4161","FOR","BK4024","BK7096","BOT","BK7502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636866149","title":"Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2636866149","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636866149?lang=en_us&edition=fundamental","pubTime":"2026-05-20 02:15","pubTimestamp":1779214500,"startTime":"0","endTime":"0","summary":"ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDA No new safety signals identified by the independent Data Safety Monitoring Committee over 52 week","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297888/0/en/Achieve-Life-Sciences-Presents-Safety-Data-from-52-Weeks-of-Continuous-Cytisinicline-Treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636970009","title":"Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636970009","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636970009?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:30","pubTimestamp":1779136200,"startTime":"0","endTime":"0","summary":"Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with mo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3297034/0/en/Wave-Life-Sciences-Announces-Positive-Update-on-RestorAATion-2-Trial-WVE-006-GalNAc-RNA-Editing-Achieves-MZ-Like-Phenotype-Across-Both-Biweekly-and-Monthly-Dosing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","WVE","BK4007","IE0009354923.USD","BK4585","BK4139","ATS","BK4505","RNA","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636072000","title":"Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636072000","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636072000?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:30","pubTimestamp":1779118200,"startTime":"0","endTime":"0","summary":"– Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the Asthma Control Questionnaire-6 (ACQ-6) in participants with CRSwNP and c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296828/0/en/Upstream-Bio-Presents-New-Data-from-Phase-2-VIBRANT-Trial-of-Verekitug-Demonstrating-Improvement-in-Asthma-Symptom-Control-in-Participants-with-CRSwNP-and-Comorbid-Asthma-at-the-AT.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636072503","title":"ATS Corporation Sets May 28, 2026 Fourth-Quarter Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2636072503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636072503?lang=en_us&edition=fundamental","pubTime":"2026-05-18 22:47","pubTimestamp":1779115643,"startTime":"0","endTime":"0","summary":"The latest update is out from ATS Corporation ( ($TSE:ATS) ). ATS Corporation said on May 14, 2026, that it will release financial results for its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ats-corporation-sets-may-28-2026-fourth-quarter-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ats-corporation-sets-may-28-2026-fourth-quarter-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635034943","title":"Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2635034943","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635034943?lang=en_us&edition=fundamental","pubTime":"2026-05-16 02:40","pubTimestamp":1778870414,"startTime":"0","endTime":"0","summary":"Wave Life Sciences  is expected to present new data from its RestorAATion-2 study of WVE-006 at the ATS 2026 conference that could further strengthen confidence in its RNA editing platform, Wedbush Securities said in a note Friday.The brokerage said in a Friday research note that the upcoming results could show a consistent improvement pattern versus earlier cohorts, including higher editing efficiency and sustained protein responses across dose groups.The investment firm added that the data may support clinically meaningful levels of alpha-1 antitrypsin production. It added that the durability of the response could enable monthly or less frequent dosing intervals.Wedbush has an outperform rating and a $15 price target on Wave Life Sciences.Shares of the company were down 2.6% in Friday trading.Price: 6.72, Change: -0.18, Percent Change: -2.61","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","RNA","BK4585","BK4588","ATS","BK4161","IE0009354923.USD","WVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635899440","title":"Press Release: MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2635899440","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635899440?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:30","pubTimestamp":1778844600,"startTime":"0","endTime":"0","summary":"-- Randomized Phase 2 trial initiated for agenT-797 in severe acute lung. injury and respiratory distress, with preliminary data expected in the. -- AACR and ASGCT presentations showcase durable survival and. context-dependent iNKT activity in cancer and inflammatory lung disease. -- Non-dilutive collaborations expand MiNK's platform and potentiate. meaningful commercial revenue potential, while preserving focus on lead. Dr. Buell continued, \"What continues to distinguish agenT-797 is both its biology and its practicality. As an off-the-shelf iNKT cell therapy administered without lymphodepletion or HLA matching, agenT-797 is designed for settings where immune dysfunction drives poor outcomes and where speed, tolerability and deployability matter. We believe this is particularly relevant in severe acute lung injury and critical illness, where patients often face a cascade of respiratory failure, secondary infection and organ dysfunction with limited therapeutic options.\". MiNK initiate","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139","ATS","IBRX","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635086190","title":"Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses","url":"https://stock-news.laohu8.com/highlight/detail?id=2635086190","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635086190?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:00","pubTimestamp":1778842800,"startTime":"0","endTime":"0","summary":"Late-breaking presentation at SID and featured presentation at the ATS Respiratory Innovation Summit highlight KT-621 BroADen Phase 1b clinical data and potential across Type 2 inflammatory diseases K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295720/0/en/Kymera-Therapeutics-Announces-Presentations-on-KT-621-a-First-In-Class-Oral-STAT6-Degrader-at-the-Society-for-Investigative-Dermatology-and-American-Thoracic-Society-Congresses.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","BK4006","LU0320765646.SGD","SG9999004220.SGD","AD","ATS","BK4132","AFG","BK4139","BK4115","PN","LU0300736062.USD","LU0006061336.USD","BK4107","BK4201","LU0072461881.USD","BPH","SID","LU1162221912.USD","KYMR","BK4117","BK4588","BK4585","BP","LU0541501648.USD","LU1829250122.USD","BK4096","LU0300736492.USD","BK4161","KT","LU0541502299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635721862","title":"Press Release: ATS to Host Fourth Quarter Earnings Call Thursday May 28, 2026, at 8:30 a.m. Eastern","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721862","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721862?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:23","pubTimestamp":1778793780,"startTime":"0","endTime":"0","summary":"ATS Corporation    will report its financial results for the fourth quarter ended March 31, 2026, before markets open on Thursday May 28, 2026.A replay of the conference will be available on the ATS website following the call. Alternatively, a telephone recording of the call will be available for one week  by dialing  770-2030 and entering passcode 8782510.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HST","ATS","EML"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635372501","title":"Press Release: Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635372501","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635372501?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":"TORONTO, May 14, 2026  -- Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2026 and provided an update on its business.During the second quarter, Edesa continued preparations for an upcoming Phase 2 clinical study of its drug candidate, EB06 , in moderate-to-severe nonsegmental vitiligo patients. The company reported that it has contracted a clinical research organization and initiated outreach to potential clinical sites and investigators. Based on this progress, Edesa reaffirmed its previous guidance that site activations and patient recruitment are expected to begin midyear 2026, subject to regulatory approval. For its respiratory program, the company also announced during the quarter additional positive data from its Phase 3 study of paridiprubart in subjects with Acute Respiratory Distress Syndrome. Most no","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS","BK4588","BK4581","BK4139","BK4161","EDSA","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635785056","title":"Press Release: Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2635785056","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635785056?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"-- Company rapidly advancing Phase 3 programs designed to deliver best-in-class efficacy with convenient quarterly dosing in severe asthma and CRSwNP --. -- End-of-Phase 2 meetings with FDA planned for mid-2026; Phase 3 initiations in both indications expected in Q1 2027 --. \"We continue to make strong progress advancing our clinical programs in severe asthma and CRSwNP to position verekitug as a uniquely differentiated treatment option for these diseases,\" said Rand Sutherland, MD, Chief Executive Officer of Upstream Bio. \"We are working diligently to deliver best-in-class efficacy with convenient quarterly at-home dosing, a profile that we believe will advance the standard of care for patients and maximize the potential commercial value of verekitug. We are continuing to prepare for our End-of-Phase 2 meetings with the FDA, which we expect to occur in mid-2026, and we remain on track to initiate Phase 3 dosing in both severe asthma and CRSwNP in the first quarter of 2027.\"","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","TSLP","ATS","BK4139","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635000172","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2635000172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635000172?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:00","pubTimestamp":1778666400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Copa Hldgs A                                     1Q      4.14    4:30 PM. ·FLEX LNG Ltd                                    1Q       .36    1:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSH","CING","AEBI","BTGO","CSCO","ATAT","PYPD","CAAP","CLPT","BBWI","BTDR","CNTB","AUTL","BOOT","CCAP","GOOS","AMAT","ATS","CLNN","KARO","DERM","CPA","AKA","BHST","BABA","BIRK","CBUS","ATYR","AVAH","PHVS","BWAY","CLBT","CMPS","ACOG","BN","CELC","BEEM","ARX","ALLO","CSWC","ALT","BGSI","AYTU","ABEO","BTBT","BZAI","AQST","CSIQ","CCCC","BEAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634496465","title":"RBC Capital Keeps Their Buy Rating on ATS Corporation (ATS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634496465","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634496465?lang=en_us&edition=fundamental","pubTime":"2026-05-09 09:54","pubTimestamp":1778291662,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sabahat Khan from RBC Capital maintained a Buy rating on ATS Corporation, with a price target of C$51.00. According...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-ats-corporation-ats-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-ats-corporation-ats-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633439685","title":"Australis Oil & Gas launches market-linked long term incentive plan for employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2633439685","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633439685?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:20","pubTimestamp":1778232039,"startTime":"0","endTime":"0","summary":"An update from Australis Oil & Gas ( ($AU:ATS) ) is now available. Australis Oil & Gas has outlined a new employee long term incentive program for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/australis-oil-gas-launches-market-linked-long-term-incentive-plan-for-employees?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/australis-oil-gas-launches-market-linked-long-term-incentive-plan-for-employees?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATS","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633714767","title":"Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633714767","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633714767?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:44","pubTimestamp":1778157840,"startTime":"0","endTime":"0","summary":"20+ presentations highlight expanding role in pediatric lung disease, treatment-response assessment, and pharma trial endpoints. Xenon MRI continues to evolve into a practical cardiopulmonary biomarker platform for clinical trials and therapeutic development","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290044/0/en/Xenon-MRI-Advances-as-a-Cardiopulmonary-Biomarker-Platform-at-ATS-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145553","title":"Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145553","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145553?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151600,"startTime":"0","endTime":"0","summary":"Recent BEAM-302 Topline Data in Alpha-1 Antitrypsin Deficiency (AATD) Demonstrate Strong Single-dose Safety and Efficacy Profile, with 60 mg Selected as Optimal Biological Dose; Global Pivotal Cohort ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289806/0/en/Beam-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Recent-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","LENZ","BK4611","BK4505","SCD","ATS","BK4585","LU1861559042.SGD","BK4588","BK4161","BK4535","BK4007","LU1861558580.USD","BK4539","BK4139","BEAM","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633976345","title":"Entravision’s Earnings Call: ATS Fuels Profitable Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2633976345","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633976345?lang=en_us&edition=fundamental","pubTime":"2026-05-06 08:15","pubTimestamp":1778026548,"startTime":"0","endTime":"0","summary":"Entravision Communications Corporation Class A (($EVC)) has held its Q1 earnings call. Read on for the main highlights of the call. Entravision Com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/entravisions-earnings-call-ats-fuels-profitable-turnaround?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/entravisions-earnings-call-ats-fuels-profitable-turnaround?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVC","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633924297","title":"Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924297?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011500,"startTime":"0","endTime":"0","summary":"Completed follow-on common stock offering with net proceeds of ~$162 million, extending expected cash runway into 2030 through potential FDA approval of Haduvio in IPF-related chronic cough and contin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3288254/0/en/Trevi-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4585","BK4139","BK4007","LABU","ATS","RCC","BK4539","BK4588","BK4161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":118,"code":"91000000","status":"200"}]}}